Abnormal levels of proinflammatory cytokines in serum and monocyte cultures from patients with chronic myeloid leukemia in different stages, and their role in prognosis

Citation
M. Anand et al., Abnormal levels of proinflammatory cytokines in serum and monocyte cultures from patients with chronic myeloid leukemia in different stages, and their role in prognosis, HEMATOL ONC, 16(4), 1998, pp. 143-154
Citations number
37
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
HEMATOLOGICAL ONCOLOGY
ISSN journal
02780232 → ACNP
Volume
16
Issue
4
Year of publication
1998
Pages
143 - 154
Database
ISI
SICI code
0278-0232(199812)16:4<143:ALOPCI>2.0.ZU;2-D
Abstract
Interleukin-1 (IL-1), interleukin-6 (IL-6) and tumor necrosis factor-a (TNF -a), primarily monocyte-derived cytokines, form a group of proinflammatory cytokines with related and overlapping spectra of activities. The role of t hese cytokines in chronic myeloid leukemia (CML) has been investigated. A d istinctive pattern of cytokine secretion has been found in chronic myeloid leukemia in chronic phase (CML-CP), in blastic crisis (CML-BC) and in norma l subjects. Serum IL-6 levels in CML-CP and CML-BC were significantly raise d compared with normal controls (p=0.0026 for CML-CP and p=0.0011 for CML-B C). IL-6 was significantly elevated in blastic crisis of CML (103.5 +/- 20. 77 pg ml(-1)) compared with CML-CP (37.35 +/- 10.88 pg ml(-1) p = 0.014). I L-6 serum levels were found to correlate significantly with peripheral bloo d monocyte counts and bone marrow blast and basophil counts. We have analys ed monocyte/macrophage function with respect to their ability to produce IL -1, IL-6 and TNF-a, spontaneously as well as in response to LPS, in compari son with normal controls. A direct correlation of IL-6 levels in unstimulat ed and stimulated cultures with bone marrow blast and basophil counts has b een observed. From these results it is inferred that the monocyte function is impaired in CML patients, and the cytokine secretion is deficient. Our l imited data suggest that serum IL-6 levels may play an important role as a prognostic marker for CML. Copyright (C) 1998 John Wiley & Sons, Ltd.